Follow
Sukrut H. Karandikar
Sukrut H. Karandikar
Unknown affiliation
Verified email at bwh.harvard.edu
Title
Cited by
Cited by
Year
A polymer nanostructured Fabry–Perot interferometer based biosensor
T Zhang, P Pathak, S Karandikar, R Giorno, L Que
Biosensors and Bioelectronics 30 (1), 128-132, 2011
402011
Biochemical sensing with a polymer-based micromachined Fabry-Perot sensor
T Zhang, S Talla, Z Gong, S Karandikar, R Giorno, L Que
Optics Express 18 (17), 18394-18400, 2010
362010
Composite nanomaterial thin film-based biosensors
Z Gong, S Karandikar, X Zhang, V Kotipalli, Y Lvov, L Que
SENSORS, 2010 IEEE, 29-32, 2010
292010
Identification of epitopes in ovalbumin that provide insights for cancer neoepitopes
SH Karandikar, J Sidney, A Sette, MJ Selby, AJ Korman, PK Srivastava
JCI insight 4 (8), 2019
272019
Raman and quantitative phase imaging allow morpho-molecular recognition of malignancy and stages of B-cell acute lymphoblastic leukemia
SK Paidi, P Raj, R Bordett, C Zhang, SH Karandikar, R Pandey, I Barman
Biosensors and Bioelectronics 190, 113403, 2021
252021
Reagent-free and rapid assessment of T cell activation state using diffraction phase microscopy and deep learning
S Karandikar, C Zhang, A Meiyappan, I Barman, C Finck, PK Srivastava, ...
Analytical Chemistry, 2019
242019
Prediction of cancer neoepitopes needs new rules
CA Brennick, MM George, PK Srivastava, SH Karandikar
Seminars in Immunology 47, 101387, 2020
232020
microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance
M Fujiwara, R Raheja, LP Garo, AK Ajay, R Kadowaki-Saga, ...
The Journal of clinical investigation 132 (10), 2022
202022
Label-free biosensing using a nanostructured Fabry-Perot interferometer
T Zhang, S Karandikar, Z Gong, R Giorno, L Que
SENSORS, 2010 IEEE, 2065-2068, 2010
42010
CD8+ T Cell–Dependent Antitumor Activity In Vivo of a Mass Spectrometry–Identified Neoepitope despite Undetectable CD8+ Immunogenicity In Vitro
MA Gillig, CA Brennick, MM George, JL Balsbaugh, TV Shcheglova, ...
The Journal of Immunology, 2023
12023
Reagent-free Raman and quantitative phase imaging offer a unique morpho-molecular platform for recognition of malignancy and stages of B-cell acute lymphoblastic leukemia
SK Paidi, P Raj, R Bordett, C Zhang, SH Karandikar, R Pandey, I Barman
bioRxiv, 2021.01. 25.428006, 2021
12021
CD8 T Cell− Dependent Antitumor Activity In Vivo of a Mass Spectrometry− Identified Neoepitope despite Undetectable CD8 Immunogenicity In Vitro
MA Gillig, CA Brennick, MM George, JL Balsbaugh, TV Shcheglova, ...
2023
Activation of virtual memory CD8+ T cells specific for self antigens requires antigen presentation by CD11c+ cells
MA Gillig, SH Karandikar, PK Srivastava
The Journal of Immunology 204 (1_Supplement), 140.19-140.19, 2020
2020
Unbiased testing of all single nucleotide variants specific to a tumor for anti-tumor CD8+ T cell immune response
SH Karandikar, TV Shcheglova, AT Hagymasi, CA Brennick, II Mandoiu, ...
The Journal of Immunology 200 (1_Supplement), 57.16-57.16, 2018
2018
A Study of MHC class I-restricted Antigenicity of Ovalbumin in Pursuit of the Definition of Tumor Specific Epitopes Involved in Tumor Rejection
SH Karandikar
2017
Kb-restricted epitopes of ovalbumin
SH Karandikar, PK Srivastava
MOLECULAR IMMUNOLOGY 68 (2), 144-144, 2015
2015
Determinants of immunogenicity: flogging the old ovalbumin, again (APP5P. 116)
S Karandikar, P Srivastava
The Journal of Immunology 194 (1_Supplement), 183.18-183.18, 2015
2015
Eight novel H-2Kb and H-2Db restricted epitopes of ovalbumin (APP2P. 109)
S Karandikar, P Srivastava
The Journal of Immunology 192 (1 Supplement), 43.10-43.10, 2014
2014
A Nanocomposite Microwire Electric Biosensor
SH Karandikar
Louisiana Tech University, 2011
2011
The system can't perform the operation now. Try again later.
Articles 1–19